Company intelligence / Profile preview

Intent Solutions

Atlanta, Georgia, United Statesintentsolutions.com ↗

Ownership: Private
Development stage: Commercial

Overview

The TAD device by Intent Solutions has demonstrated utility in improving patient outcomes by ensuring medications are taken as prescribed. It provides real-time or near-real-time data on patient compliance for clinicians, researchers, and healthcare providers. The system has been piloted successfully in settings such as hepatitis C elimination projects to ensure high cure rates through improved adherence. No traditional clinical trial results since it’s a device/service.

Therapeutic areas: OtherPsychiatryInfectious Diseases
Modalities: Device (programmable medication dispenser)
Industry: Therapeutic Medical Devices

Partnerships

AT&T (for LTE-M IoT connectivity integration into the TAD device)

Beyond the preview

Go deeper on Intent Solutions.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Intent Solutions.

Explore the full profile